Global Custom Market Research Reports Provider Company

phone

Achaogen Inc (AKAO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • Published Date: 11 Apr 2018
  • Number of Pages: 49
  • Category: Pharmaceuticals
  • Country: United States of America
Summary

Achaogen Inc (Achaogen) is a biopharmaceutical company that discovers, develops and commercializes novel anti bacterials for the treatment of multi-drug resistant and gram-negative infections. The company is developing plazomicin for the treatment of serious bacterial infections due to MDR Enterobacteriaceae. Its pipeline products include C-scape, lpxC inhibitors, and others. Achaogens C-Scape is a combination of an approved beta-lactam and an approved beta-lactamase inhibitor that can treat patients with complex urinary tract infections due to MDR pathogens. The company collaborates with the antibacterial drug development companies and academic researchers in the field of antibiotic pharmacology. Achaogen is headquartered in San Francisco, California, the US.

Achaogen Inc (AKAO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons To Buy


Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.
Publisher Name : GlobalData

3
List of Tables 5
List of Figures 5
Achaogen Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Achaogen Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Achaogen Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Achaogen Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Achaogen Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Achaogen Inc, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Achaogen Raises US$19 Million In Venture Financing 11
Partnerships 12
Achaogen Enters into Agreement with Microgenics 12
Licensing Agreements 13
Achaogen Enters into Licensing Agreement with Crystal Bioscience 13
Achaogen Enters into Licensing Agreement with Trianni 14
Equity Offering 15
Achaogen to Raise up to USD50 Million in Public Offering of Shares 15
Achaogen Raises USD112.5 Million in Public Offering of Shares 16
Achaogen to Raise USD10 Million in Private Placement of Shares 18
Achaogen Receives USD5.3 Million in Public Offering of Shares 19
Achaogen Raises USD101 Million in Public Offering of Shares 20
Achaogen Raises USD25 Million in Private Placement of Shares 22
Achaogen Completes IPO For US$82.8 Million 23
Achaogen Inc - Key Competitors 24
Achaogen Inc - Key Employees 25
Achaogen Inc - Locations And Subsidiaries 26
Head Office 26
Recent Developments 27
Financial Announcements 27
Feb 27, 2018: Achaogen Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Corporate Update 27
Nov 08, 2017: Achaogen Reports Third Quarter 2017 Financial Results and Provides Corporate Update 29
Aug 03, 2017: Achaogen Reports Second Quarter 2017 Financial Results and Provides Corporate Update 30
May 08, 2017: Achaogen Reports First Quarter 2017 Financial Results and Provides Corporate Update 32
Mar 14, 2017: Achaogen Reports Fourth Quarter and Full Year 2016 Financial Results and Provides Corporate Update 34
Corporate Communications 36
Dec 11, 2017: Achaogen Appoints Blake Wise Chief Executive Officer 36
Sep 18, 2017: Achaogen Adds Liz Bhatt as Chief Business Officer 37
Jul 13, 2017: Achaogen Appoints Dr. Karen Bernstein to its Board of Directors 38
Feb 27, 2017: Achaogen Adds Janet Dorling as Chief Commercial Officer 39
Feb 23, 2017: Achaogen Announces Leadership Promotions 40
Jan 05, 2017: Achaogen appoints new board member 41
Government and Public Interest 42
May 05, 2017: Achaogen Receives Investment from the Bill & Melinda Gates Foundation to Develop Antibodies Against Gram-Negative Bacteria 42
Product News 43
07/25/2017: Achaogen Wins CARB-X Funding Award to Advance Development of LpxC Inhibitor Antibiotic to Fight Drug Resistant Infections 43
Mar 01, 2017: Achaogen Highlights Emerging Pipeline of Antibacterials Including a new Orally-Administered Antibiotic Clinical Candidate at Companys R&D Day 44
Clinical Trials 45
Jan 02, 2018: Achaogen Announces Positive Top-Line Results from First Clinical Trial of Orally-Administered Antibacterial Candidate C-Scape 45
Sep 28, 2017: Achaogen Awarded up to $18 Million Contract by BARDA to Support Development of Orally-Administered Antibacterial Candidate C-Scape 47
Jun 01, 2017: Achaogen Initiates C-Scape Clinical Development Program with Phase 1 Study of Orally-Administered Antibacterial Candidate 48
Appendix 49
Methodology 49
About GlobalData 49
Contact Us 49
Disclaimer 49

List Of Tables

List of Tables
Achaogen Inc, Pharmaceuticals & Healthcare, Key Facts, 2016 2
Achaogen Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Achaogen Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Achaogen Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Achaogen Inc, Deals By Therapy Area, 2012 to YTD 2018 9
Achaogen Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Achaogen Raises US$19 Million In Venture Financing 11
Achaogen Enters into Agreement with Microgenics 12
Achaogen Enters into Licensing Agreement with Crystal Bioscience 13
Achaogen Enters into Licensing Agreement with Trianni 14
Achaogen to Raise up to USD50 Million in Public Offering of Shares 15
Achaogen Raises USD112.5 Million in Public Offering of Shares 16
Achaogen to Raise USD10 Million in Private Placement of Shares 18
Achaogen Receives USD5.3 Million in Public Offering of Shares 19
Achaogen Raises USD101 Million in Public Offering of Shares 20
Achaogen Raises USD25 Million in Private Placement of Shares 22
Achaogen Completes IPO For US$82.8 Million 23
Achaogen Inc, Key Competitors 24
Achaogen Inc, Key Employees 25

List Of Figures

List of Figures
Achaogen Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Achaogen Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Achaogen Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Achaogen Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Achaogen Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Achaogen Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Achaogen Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

Physiomics plc (Physiomics) is a computational systems biology services company. It is involved in developing outsourced systems and computational systems biology models for predicting and understanding cancer drug efficacy from

View Report

Pharmstandard develops, manufactures and distributes pharmaceutical products. The company offers prescription pharmaceuticals and over-the drug (OTC) pharmaceuticals. It also provides active pharmaceutical ingredients and contract manufacturing services. Pharmstandards product portfolio

View Report

Orexigen Therapeutics Inc (Orexigen) is a biopharmaceutical company which develops and commercializes indications for the treatment of obesity. Its lead product, Contrave (naltrexone HCl / bupropion HCl prolonged release) is

View Report
There is no reviews available for this report

Select License Type

Delivery Details

Delivery Details : Electronic files (PDF) of market research reports will dispatched within 12 to 24 hours. (Mon-Fri IST)

Customized Report

If a particular report is not as per your requirement you can ‎choose "Customized Report". To visit click on -

Custom Research Reports